Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Preparation and purification of recombinant outer surface protein A (rOspA) of Borrelia burgdorferi sensu stricto and Borrelia afzelii

J. Bĕláková, M. Krupka, M. Sebestová, J. Tuhácková, V. Vrzal, M. Raska, E. Weigl

. 2005 ; 149 (2) : 257-259.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc13003763

The recombinant Outer surface protein A (rOspA) from Borrelia burgdorferi is a possible immunogen for protection of infected humans and animals against development of Lyme borreliosis (Lyme disease), a chronic tick-borne disease characterised by diverse dermatologic, neurologic, rheumatic, and cardiac manifestations. For several years, research and development have been directed towards a vaccine for the prevention of this debilitating disease. Numerous animal studies demonstrate that pre-existing antibodies against the outer surface proteins of B. burgdorferi can prevent infection and disease caused by this organism. In this communication, using recombinant DNA technology, genes from B. burgdorferi sensu stricto and B. afzelii were inserted into E. coli-expression vectors and the rOspA were produced. Our aim was to obtain rOspA protein in a purity and quantity desirable for immunization of experimental animals. rOspA is currently the most developed, molecularly-defined vaccine candidate for the prevention of Lyme borreliosis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13003763
003      
CZ-PrNML
005      
20130228115623.0
007      
ta
008      
130128s2005 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2005.035 $2 doi
035    __
$a (PubMed)16601765
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Běláková, Jana. $7 _AN054676 $u Department of Immunology, Palacký University, Olomouc
245    10
$a Preparation and purification of recombinant outer surface protein A (rOspA) of Borrelia burgdorferi sensu stricto and Borrelia afzelii / $c J. Bĕláková, M. Krupka, M. Sebestová, J. Tuhácková, V. Vrzal, M. Raska, E. Weigl
520    9_
$a The recombinant Outer surface protein A (rOspA) from Borrelia burgdorferi is a possible immunogen for protection of infected humans and animals against development of Lyme borreliosis (Lyme disease), a chronic tick-borne disease characterised by diverse dermatologic, neurologic, rheumatic, and cardiac manifestations. For several years, research and development have been directed towards a vaccine for the prevention of this debilitating disease. Numerous animal studies demonstrate that pre-existing antibodies against the outer surface proteins of B. burgdorferi can prevent infection and disease caused by this organism. In this communication, using recombinant DNA technology, genes from B. burgdorferi sensu stricto and B. afzelii were inserted into E. coli-expression vectors and the rOspA were produced. Our aim was to obtain rOspA protein in a purity and quantity desirable for immunization of experimental animals. rOspA is currently the most developed, molecularly-defined vaccine candidate for the prevention of Lyme borreliosis.
650    _2
$a antigeny povrchové $x biosyntéza $x izolace a purifikace $7 D000954
650    _2
$a proteiny vnější bakteriální membrány $x biosyntéza $x izolace a purifikace $7 D001425
650    _2
$a bakteriální vakcíny $x biosyntéza $x izolace a purifikace $7 D001428
650    _2
$a Borrelia burgdorferi $x imunologie $7 D025065
650    _2
$a Borrelia burgdorferi komplex $x imunologie $7 D015748
650    _2
$a Escherichia coli $7 D004926
650    _2
$a genetické vektory $7 D005822
650    _2
$a lipoproteiny $x biosyntéza $x izolace a purifikace $7 D008074
650    _2
$a vakcína proti lymeské nemoci $x biosyntéza $7 D022123
650    _2
$a DNA vakcíny $x biosyntéza $x izolace a purifikace $7 D019444
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Křupka, Michal $7 xx0106791 $u Department of Immunology, Palacký University, Olomouc
700    1#
$a Šebestová, Martina. $7 _AN060155 $u Department of Immunology, Palacký University, Olomouc
700    1#
$a Tuháčková, Jana. $7 _AN071539 $u Bioveta, a. s., Ivanovice na Hane
700    1#
$a Vrzal, Vladimír. $7 _AN053149 $u Bioveta, a. s., Komenskeho 212, 683 23 Ivanovice na Hane, Czech Republic
700    1_
$a Raška, Milan, $d 1967- $7 xx0060585 $u Department of Immunology, Palacký University, Olomouc
700    1_
$a Weigl, Evžen, $d 1948- $7 xx0060584 $u Department of Immunology, Palacký University, Olomouc
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 149, č. 2 (2005), s. 257-259
910    __
$a ABA008 $b A 1502 $c sign $y 3 $z 0
990    __
$a 20130128 $b ABA008
991    __
$a 20130228115824 $b ABA008
999    __
$a ok $b bmc $g 966418 $s 801958
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2005 $b 149 $c 2 $d 257-259 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20130128

Find record

Citation metrics

Archiving options